LBRXLB PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of LB PHARMACEUTICALS INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBRXEsta | $1.3B#7 | 1.8x#1 | 4.0x#11 | — | — | 60.1%#4 | — | -7.6%#5 | — | — | 154.2%#1 | — |
| ETON | $1.5B#1 | — | 31.4x#12 | 18.3x#7 | 104.9%#3 | -20.4%#7 | -1.1%#4 | -9.9%#6 | -1.8%#3 | 4#2 | — | — |
| PCRX | $1.5B#2 | 104.0x#6 | 2.2x#3 | 2.0x#2 | 3.6%#4 | 107.0%#1 | 2.6%#3 | 1.0%#2 | 1.0%#2 | — | — | — |
| ANAB | $1.4B#3 | 8.6x#3 | 135.5x#13 | 6.1x#4 | 157.0%#2 | 90.9%#3 | 96.7%#1 | -125.0%#12 | — | — | — | — |
| MLYS | $1.4B#4 | — | 2.6x#5 | — | — | 13.0%#5 | — | -28.1%#9 | -41.3%#6 | — | — | — |
| DMRA | $1.4B#5 | 2.9x#2 | 2.7x#7 | — | — | -878.8%#13 | — | -40.7%#11 | — | — | — | — |
| OPK | $1.3B#8 | — | 1.1x#1 | 2.2x#3 | -14.9%#6 | -324.0%#12 | -19.3%#5 | -19058.1%#13 | -13.3%#4 | 4#2 | 26.5%#4 | — |
| KARD | $1.3B#6 | — | 2.2x#4 | — | — | — | — | 0.0%#3 | — | — | — | — |
| OMER | $1.3B#9 | 10.4x#4 | — | 17.7x#6 | -34.0%#7 | 97.9%#2 | -166.4%#7 | — | -151.8%#8 | — | 151.7%#2 | — |
| NKTR | $1.3B#10 | — | 1.4x#2 | 23.3x#8 | -43.9%#8 | -37.8%#8 | -253.7%#8 | -18.2%#7 | -14.0%#5 | — | — | — |
| TYRA | $1.3B#11 | — | 3.6x#10 | — | — | -38.7%#10 | — | -33.9%#10 | — | — | 40.0%#3 | — |
| SNDX | $1.3B#12 | — | — | 7.4x#5 | 627.8%#1 | 10.5%#6 | -158.4%#6 | — | -143.0%#7 | — | — | — |
| RAPP | $1.2B#13 | — | 2.9x#8 | — | — | -42.4%#11 | — | -26.4%#8 | — | — | — | — |
| AVLN | $1.2B#14 | — | 2.9x#9 | — | — | — | — | 0.0%#3 | — | — | — | — |
| AMPH | $1.2B#15 | 16.0x#5 | 2.6x#6 | 1.6x#1 | -1.7%#5 | -38.5%#9 | 19.5%#2 | 22.0%#1 | 13.2%#1 | 5#1 | 7.2%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice